Danazol for treatment of refractory autoimmune hemolytic anaemia.
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
This case study reports that danazol achieved excellent hematological remission in a pediatric patient with severe autoimmune hemolytic anemia refractory to steroids and splenectomy.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Autoimmune hemolytic anemia (AHA) is uncommon in childhood. A female child presented with severe and chronic clinical course. She was refractory to steroid and the response to splenectomy was poor. She showed excellent remission of hematological condition with Danazol. Danazol may be the drug of choice for refractory autoimmune hemolytic anemia.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (2)
References (3)
- doi:10.1017/ice.2016.95 via openalex
- doi:10.1542/peds.2018-2896 via openalex
- doi:10.1016/s0140-6736(17)31444-7 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-05-10T18:01:37.864769+00:00
License: CC0
· commercial use OK